Novo Nordisk is the sole patent holder of semaglutide and does not sell that ingredient to outside entities. It's unclear what the spas and clinics are actually selling to consumers. Novo Nordisk asked the courts for orders blocking the sales of the unauthorized drugs and an unspecified amount of money damages. "These unlawful marketing and sales practices, including the use of Novo Nordisk trademarks in connection with these practices, have created a high risk of consumer confusion and deception as well as potential safety concerns," the company wrote in a press release Tuesday.